These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
29. Plasma cell granuloma of the lung following chemotherapy for lymphocytic lymphoma. Carulli G; Pingitore R; Marini A; Grassi B Haematologica; 1985; 70(4):371-2. PubMed ID: 3935541 [No Abstract] [Full Text] [Related]
30. [Limits of beryllium detection with laser microprobe mass spectrometry (LAMMS)]. Entzian P; Pawelek W; Lindner B; Schlaak M; Zabel P; Müller-Quernheim J Pneumologie; 1998 Dec; 52(12):674-9. PubMed ID: 10028838 [TBL] [Abstract][Full Text] [Related]
31. Case study: working safely with beryllium oxide. Berakis M Occup Health Saf; 2009 May; 78(5):34, 36, 38 passim. PubMed ID: 19480368 [TBL] [Abstract][Full Text] [Related]
32. [The process of the formation of sarcoid granuloma]. Dobrescu G; Dobrescu A Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1989; 38(3):213-7. PubMed ID: 2559456 [No Abstract] [Full Text] [Related]
33. Ultrafine beryllium number concentration as a possible metric for chronic beryllium disease risk. McCawley MA; Kent MS; Berakis MT Appl Occup Environ Hyg; 2001 May; 16(5):631-8. PubMed ID: 11370941 [TBL] [Abstract][Full Text] [Related]
34. Experimental beryllium-induced lung disease. I. Differences in immunologic responses to beryllium compounds in strains 2 and 13 guinea pigs. Barna BP; Deodhar SD; Chiang T; Gautam S; Edinger M Int Arch Allergy Appl Immunol; 1984; 73(1):42-8. PubMed ID: 6693180 [TBL] [Abstract][Full Text] [Related]
35. An immune model of beryllium-induced pulmonary granulomata in mice. Histopathology, immune reactivity, and flow-cytometric analysis of bronchoalveolar lavage-derived cells. Huang H; Meyer KC; Kubai L; Auerbach R Lab Invest; 1992 Jul; 67(1):138-46. PubMed ID: 1625444 [TBL] [Abstract][Full Text] [Related]
36. A canine model of beryllium-induced granulomatous lung disease. Haley PJ; Finch GL; Mewhinney JA; Harmsen AG; Hahn FF; Hoover MD; Muggenburg BA; Bice DE Lab Invest; 1989 Aug; 61(2):219-27. PubMed ID: 2755079 [TBL] [Abstract][Full Text] [Related]
37. Prevention of beryllium sensitization and chronic beryllium disease. Henneberger PK; Goe SK; Miller WE; Doney B; Groce DW J Occup Environ Hyg; 2006 Apr; 3(4):D42-3. PubMed ID: 16507518 [No Abstract] [Full Text] [Related]
38. A model of pulmonary granulomata induced by beryllium sulfate in the rat. Votto JJ; Barton RW; Gionfriddo MA; Cole SR; McCormick JR; Thrall RS Sarcoidosis; 1987 Mar; 4(1):71-6. PubMed ID: 2954196 [TBL] [Abstract][Full Text] [Related]
39. Transfer of contact sensitivity to beryllium using dialyzable leukocyte extracts (transfer factor). Epstein WL; Byers VS J Allergy Clin Immunol; 1979 Feb; 63(2):111-5. PubMed ID: 83331 [TBL] [Abstract][Full Text] [Related]
40. Some current concepts of the pneumoconioses. Aponte GE Ann Clin Lab Sci; 1973; 3(3):219-23. PubMed ID: 4349989 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]